{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/gynaecological-cancers-recognition-referral/management/referral-for-suspected-gynaecological-cancer/","result":{"pageContext":{"chapter":{"id":"415eae91-f38a-5ccc-95f0-68d5ca386095","slug":"referral-for-suspected-gynaecological-cancer","fullItemName":"Scenario: Referral for suspected gynaecological cancer","depth":2,"htmlHeader":"<!-- begin field d6067375-31e6-4dcc-8726-31c5e9268541 --><h2>Scenario: Referral for suspected gynaecological cancer</h2><!-- end field d6067375-31e6-4dcc-8726-31c5e9268541 -->","summary":"Covers the referral of people with suspected gynaecological cancer.","htmlStringContent":"<!-- begin item b74e57c7-1d84-4f25-a052-109feab245a2 --><!-- begin field c062b551-2fee-485c-85a3-acd900acfc72 --><p>From birth onwards (Female).</p><!-- end field c062b551-2fee-485c-85a3-acd900acfc72 --><!-- end item b74e57c7-1d84-4f25-a052-109feab245a2 -->","topic":{"id":"ee6103b8-1f49-5865-acd7-5a9d20d194e6","topicId":"e261ffa1-7f7e-430a-9e12-c985aaca7f4d","topicName":"Gynaecological cancers - recognition and referral","slug":"gynaecological-cancers-recognition-referral","lastRevised":"Last revised in February 2021","chapters":[{"id":"65e105c6-5f7b-59ad-9801-824c409f981c","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"e401d47d-3905-5eda-b3cd-1b4eef408bdf","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"e31afef3-1c88-506d-ad84-0a6b30b9dba1","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"278052bd-be26-5c26-84bc-2113aee7dc30","slug":"changes","fullItemName":"Changes"},{"id":"efc1c0f8-bdb1-5114-97b1-648a6a52a459","slug":"update","fullItemName":"Update"}]},{"id":"e8e62e95-f70c-5b2b-9b10-0c9c5f2e9c95","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"f85ffb79-0957-5932-821c-906cec331a84","slug":"goals","fullItemName":"Goals"},{"id":"7d1d0b80-0602-5d4c-98eb-6a49f27689c0","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"9244c05b-86d8-5f85-b189-5479cde68eeb","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"b605e7ea-7a24-5403-96d0-e0fac5a89219","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"703f3f20-548e-5808-a218-c091ab3b216f","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"f4beaa7f-d7cd-576b-8692-c4516abd0c56","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"e14ce3a1-8460-551b-a361-43faa360c514","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"47f1f404-6941-5185-bcab-0175066bad01","slug":"presentation","fullItemName":"Presentation"},{"id":"a9c43384-a7d0-51f4-8d73-6b71541884df","slug":"prevalence","fullItemName":"Prevalence"},{"id":"044108ce-710b-5ec8-a3ae-429b107039bf","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"9da77476-bb29-59ac-a917-0d3da982f80f","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"8a44798e-bc7c-5377-9f3c-b743ee5a7af7","slug":"symptoms-suggestive-of-gynaecological-cancers","fullItemName":"Symptoms suggestive of gynaecological cancers"}]},{"id":"b5a02174-cd66-5e92-9819-0302058cf230","fullItemName":"Management","slug":"management","subChapters":[{"id":"415eae91-f38a-5ccc-95f0-68d5ca386095","slug":"referral-for-suspected-gynaecological-cancer","fullItemName":"Scenario: Referral for suspected gynaecological cancer"}]},{"id":"8f87e182-3ee3-55c3-b6ff-ee2773b11083","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"7030c633-3342-56a4-872a-5d01b1950d05","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"3e4a0622-59ba-59f1-a249-25f37835db8f","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"598e9e20-db1b-5bd6-bad9-da74dd559795","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"d01e7124-01f5-52fc-a22b-2f245daf8632","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"e5593853-81b8-58eb-a621-1e437e26ef58","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"06edaae5-710d-5a2f-8d9f-e20e29be3d6e","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"4aae08c9-f011-5561-8ca0-183457de55ec","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"b5a02174-cd66-5e92-9819-0302058cf230","slug":"management","fullItemName":"Management"},"subChapters":[{"id":"0bcd4c34-6a49-5425-8dbf-7631b4314e97","slug":"referral-timelines","fullItemName":"Referral timelines","depth":3,"htmlHeader":"<!-- begin field 99e23574-95c2-40e7-ae53-1b51057beb83 --><h3>Referral timelines</h3><!-- end field 99e23574-95c2-40e7-ae53-1b51057beb83 -->","summary":null,"htmlStringContent":"<!-- begin item db235183-fecb-43f8-8a1a-e9cb2867ef61 --><!-- begin field f86fbfb5-bdd9-4602-a6f8-533189359f3c --><ul><li>The terms used in the National Institute for Health and Care Excellence (NICE) guideline <em>Suspected cancer: recognition and referral</em> are as follows:<br><ul><li>Immediate: an acute admission or referral occurring within a few hours, or even more quickly if necessary.</li><li>Urgent: to happen/be performed within 2 weeks.</li><li>Very urgent: to happen within 48 hours.</li><li>Non-urgent: the timescale generally used for a referral or investigation that is not considered very urgent or urgent.</li><li>Suspected cancer pathway referral: the patient is seen within the national target for cancer referrals.</li></ul></li></ul><!-- end field f86fbfb5-bdd9-4602-a6f8-533189359f3c --><!-- end item db235183-fecb-43f8-8a1a-e9cb2867ef61 -->","subChapters":[{"id":"0f13186a-8864-58df-b824-f0a52d218b59","slug":"basis-for-recommendation-321","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field 4a8b3d0d-e6a0-4274-8961-1fa6b989be84 --><h4>Basis for recommendation</h4><!-- end field 4a8b3d0d-e6a0-4274-8961-1fa6b989be84 -->","summary":null,"htmlStringContent":"<!-- begin item 3210635e-bb73-46b7-a629-9497268c21fd --><!-- begin field 4a52acc7-d749-4252-80a5-8b08420db53c --><p>This is a direct implementation of the National Institute for Health and Care Excellence guideline <em>Suspected cancer: recognition and r</em><em>eferral </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/gynaecological-cancers-recognition-referral/references/\">NICE, 2015</a>].</p><!-- end field 4a52acc7-d749-4252-80a5-8b08420db53c --><!-- end item 3210635e-bb73-46b7-a629-9497268c21fd -->","subChapters":[]}]},{"id":"47780833-d6ab-5590-bda8-032ab306b431","slug":"referral-for-suspected-ovarian-cancer","fullItemName":"Referral for suspected ovarian cancer","depth":3,"htmlHeader":"<!-- begin field 26691ef4-800d-41ab-b3b9-94f08dde1b4a --><h3>When should I refer a person with suspected ovarian cancer?</h3><!-- end field 26691ef4-800d-41ab-b3b9-94f08dde1b4a -->","summary":null,"htmlStringContent":"<!-- begin item 1b2e29d0-2a7f-459a-a30c-fc163f7b252c --><!-- begin field f3bc71f8-055d-4041-8f67-c857fb678704 --><ul><li>The recommendations for ovarian cancer apply to women aged 18 years and over.</li><li><strong>Refer the woman urgently if physical examination identifies ascites and/or a pelvic or abdominal mass (which is not obviously uterine fibroids).</strong></li><li><strong>Carry out tests in primary care if a woman (especially if 50 years or over) reports having any of the following symptoms on a persistent or frequent basis </strong>— particularly more than 12 times per month:<ul><li>Persistent abdominal distension (women often refer to this as 'bloating').</li><li>Feeling full (early satiety) and/or loss of appetite.</li><li>Pelvic or abdominal pain.</li><li>Increased urinary urgency and/or frequency.</li></ul></li><li><strong>Consider carrying out tests in primary care if a woman reports unexplained weight loss, fatigue, or changes in bowel habit.</strong></li><li>Advise any woman who is not suspected of having ovarian cancer to return if her symptoms become more frequent and/or persistent.</li><li>Carry out appropriate tests for ovarian cancer in any woman of 50 years or over who has experienced symptoms within the last 12 months that suggest irritable bowel syndrome (IBS). IBS rarely presents for the first time in women of this age.</li><li>Measure serum CA125 in primary care in women with symptoms that suggest ovarian cancer.</li><li>If serum CA125 is 35 IU/ml or greater, arrange an ultrasound scan of the abdomen and pelvis.</li><li><strong>If the ultrasound suggests ovarian cancer, refer the woman urgently for further investigation.</strong></li><li>For any woman who has normal serum CA125 (less than 35 IU/ml), or CA125 of 35 IU/ml or greater but a normal ultrasound:<ul><li>Assess her carefully for other clinical causes of her symptoms and investigate if appropriate.</li><li>If no other clinical cause is apparent, advise her to return if her symptoms become more frequent and/or persistent.</li></ul></li></ul><!-- end field f3bc71f8-055d-4041-8f67-c857fb678704 --><!-- end item 1b2e29d0-2a7f-459a-a30c-fc163f7b252c -->","subChapters":[{"id":"33d1befe-267b-5669-b459-d4d90124f5a2","slug":"basis-for-recommendation-5e1","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field 2c35b8fa-d657-42cd-a8fe-cafb8aa1b69f --><h4>Basis for recommendation</h4><!-- end field 2c35b8fa-d657-42cd-a8fe-cafb8aa1b69f -->","summary":null,"htmlStringContent":"<!-- begin item 5e1362b5-69eb-4683-92e5-fb4cd63c4ddc --><!-- begin field 4e95c967-4d01-455b-b31c-9af78591b405 --><p>This is a direct implementation of the National Institute for Health and Care Excellence guideline <em>Suspected cancer: recognition and r</em><em>eferral</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/gynaecological-cancers-recognition-referral/references/\">NICE, 2015</a>].</p><!-- end field 4e95c967-4d01-455b-b31c-9af78591b405 --><!-- end item 5e1362b5-69eb-4683-92e5-fb4cd63c4ddc -->","subChapters":[]}]},{"id":"6d68de9d-40cb-5b49-9248-6be89fb5fb74","slug":"referral-for-suspected-endometrial-cancer","fullItemName":"Referral for suspected endometrial cancer","depth":3,"htmlHeader":"<!-- begin field 14ec7ab6-0c3d-49e9-b734-3b944eff9139 --><h3>When should I refer a person with suspected endometrial cancer?</h3><!-- end field 14ec7ab6-0c3d-49e9-b734-3b944eff9139 -->","summary":null,"htmlStringContent":"<!-- begin item 1c7b98ff-f41e-4f1c-90c6-6c536a884297 --><!-- begin field 7e447dca-99b8-4c92-be8a-c5084153cdff --><ul><li><strong>Refer women using a suspected cancer pathway referral (for an appointment within 2 weeks) for endometrial cancer if they are aged 55 years and over with post-menopausal bleeding (unexplained vaginal bleeding more than 12 months after menstruation has stopped because of the menopause).</strong></li><li><strong>Consider a suspected cancer pathway referral (for an appointment within 2 weeks) for endometrial cancer in women aged under 55 years with post-menopausal bleeding.</strong></li><li><strong>Consider a direct access ultrasound scan to assess for endometrial cancer in women aged 55 years and over with:</strong><ul><li>Unexplained symptoms of vaginal discharge who:<ul><li>Are presenting with these symptoms for the first time, or</li><li>Have thrombocytosis, or</li><li>Report haematuria, or</li></ul></li><li>Visible haematuria, and:<ul><li>Low haemoglobin levels, or</li><li>Thrombocytosis, or</li><li>High blood glucose levels.</li></ul></li></ul></li></ul><!-- end field 7e447dca-99b8-4c92-be8a-c5084153cdff --><!-- end item 1c7b98ff-f41e-4f1c-90c6-6c536a884297 -->","subChapters":[{"id":"b2d3ff92-35c9-5887-9cb3-f1bc64d6af21","slug":"basis-for-recommendation-666","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field c92b05d6-f3e1-4c82-b585-bd6757d2b013 --><h4>Basis for recommendation</h4><!-- end field c92b05d6-f3e1-4c82-b585-bd6757d2b013 -->","summary":null,"htmlStringContent":"<!-- begin item 6666b619-fbf4-421b-92c1-4b9bc1b5eae1 --><!-- begin field 675fc1b2-678d-4301-bc05-e62f7e782dea --><p>This is a direct implementation of the National Institute for Health and Care Excellence guideline <em>Suspected cancer: recognition and r</em><em>eferral</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/gynaecological-cancers-recognition-referral/references/\">NICE, 2015</a>].</p><!-- end field 675fc1b2-678d-4301-bc05-e62f7e782dea --><!-- end item 6666b619-fbf4-421b-92c1-4b9bc1b5eae1 -->","subChapters":[]}]},{"id":"48d2ca0c-b415-5d17-92bb-aa9aca09b911","slug":"referral-for-suspected-cervical-cancer","fullItemName":"Referral for suspected cervical cancer","depth":3,"htmlHeader":"<!-- begin field ae41e839-fcda-4460-9d4e-99de125201ba --><h3>When should I refer a person with suspected cervical cancer?</h3><!-- end field ae41e839-fcda-4460-9d4e-99de125201ba -->","summary":null,"htmlStringContent":"<!-- begin item cd89af26-a45c-4586-a192-9b17a8d67d7c --><!-- begin field a43cc419-ed0b-43cb-8c82-8083e1327d25 --><ul><li>Consider a suspected cancer pathway referral (for an appointment within 2 weeks) for women if, on examination, the appearance of their cervix is consistent with cervical cancer.</li></ul><!-- end field a43cc419-ed0b-43cb-8c82-8083e1327d25 --><!-- end item cd89af26-a45c-4586-a192-9b17a8d67d7c -->","subChapters":[{"id":"9386d2f1-f0ea-5c41-b187-386553c24544","slug":"basis-for-recommendation-c64","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field 3f2f6e55-f0be-49df-a22a-b0a3bf1ce7c2 --><h4>Basis for recommendation</h4><!-- end field 3f2f6e55-f0be-49df-a22a-b0a3bf1ce7c2 -->","summary":null,"htmlStringContent":"<!-- begin item c64590d7-0652-4c9a-89d9-170b86d6494b --><!-- begin field 3ddd322a-7b1b-4b78-9fe2-b79a94fe84e9 --><p>This is a direct implementation of the National Institute for Health and Care Excellence guideline <em>Suspected cancer: recognition and r</em><em>eferral</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/gynaecological-cancers-recognition-referral/references/\">NICE, 2015</a>].</p><!-- end field 3ddd322a-7b1b-4b78-9fe2-b79a94fe84e9 --><!-- end item c64590d7-0652-4c9a-89d9-170b86d6494b -->","subChapters":[]}]},{"id":"9b7db0dc-73f8-5b85-832a-50f75e06d5cd","slug":"referral-for-suspected-vulval-cancer","fullItemName":"Referral for suspected vulval cancer","depth":3,"htmlHeader":"<!-- begin field b39ccf54-07cc-43cc-8e9d-d4d80a84899a --><h3>When should I refer a person with suspected vulval cancer?</h3><!-- end field b39ccf54-07cc-43cc-8e9d-d4d80a84899a -->","summary":null,"htmlStringContent":"<!-- begin item 1290df4c-996b-4d26-8306-bb44d8f56f73 --><!-- begin field ef203e4e-63cb-47ac-8cf9-e454a656261e --><ul><li>Consider a suspected cancer pathway referral (for an appointment within 2 weeks) for vulval cancer in women with an unexplained vulval lump, ulceration, or bleeding.</li></ul><!-- end field ef203e4e-63cb-47ac-8cf9-e454a656261e --><!-- end item 1290df4c-996b-4d26-8306-bb44d8f56f73 -->","subChapters":[{"id":"b756eece-db50-5be3-85de-0d18251b1311","slug":"basis-for-recommendation-4d3","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field 3777b2e6-b86a-4179-b319-9c32f9b6280f --><h4>Basis for recommendation</h4><!-- end field 3777b2e6-b86a-4179-b319-9c32f9b6280f -->","summary":null,"htmlStringContent":"<!-- begin item 4d39215c-9e04-4ac9-81d9-2f9732d69111 --><!-- begin field 4b0b7d21-a2bb-489c-84f2-214b84527cc7 --><p>This is a direct implementation of the National Institute for Health and Care Excellence guideline <em>Suspected cancer: recognition and r</em><em>eferral</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/gynaecological-cancers-recognition-referral/references/\">NICE, 2015</a>].</p><!-- end field 4b0b7d21-a2bb-489c-84f2-214b84527cc7 --><!-- end item 4d39215c-9e04-4ac9-81d9-2f9732d69111 -->","subChapters":[]}]},{"id":"9284b9b7-19f3-5417-8794-a8a279d79361","slug":"referral-for-suspected-vaginal-cancer","fullItemName":"Referral for suspected vaginal cancer","depth":3,"htmlHeader":"<!-- begin field 56dd340f-bc2a-49fb-a7b0-c85432f911c2 --><h3>When should I refer a person with suspected vaginal cancer?</h3><!-- end field 56dd340f-bc2a-49fb-a7b0-c85432f911c2 -->","summary":null,"htmlStringContent":"<!-- begin item f77b648b-a85f-490b-ac42-66e2aa59ae8e --><!-- begin field e68e99b7-08a2-47a1-81be-4d3a4d3c639f --><ul><li>Consider a suspected cancer pathway referral (for an appointment within 2 weeks) for vaginal cancer in women with an unexplained palpable mass in or at the entrance to the vagina.</li></ul><!-- end field e68e99b7-08a2-47a1-81be-4d3a4d3c639f --><!-- end item f77b648b-a85f-490b-ac42-66e2aa59ae8e -->","subChapters":[{"id":"4bbc28cd-3bc7-5910-a080-38b854150ec2","slug":"basis-for-recommendation-1e9","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field 313b377f-3965-4e2d-9b34-c3ad8a7ba5da --><h4>Basis for recommendation</h4><!-- end field 313b377f-3965-4e2d-9b34-c3ad8a7ba5da -->","summary":null,"htmlStringContent":"<!-- begin item 1e923fee-02d0-4682-9ffd-db824d02529f --><!-- begin field 8abbbfcc-acf1-4ac7-97f6-fdd7c9e834ad --><p>This is a direct implementation of the National Institute for Health and Care Excellence guideline <em>Suspected cancer: recognition and r</em><em>eferral</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/gynaecological-cancers-recognition-referral/references/\">NICE, 2015</a>].</p><!-- end field 8abbbfcc-acf1-4ac7-97f6-fdd7c9e834ad --><!-- end item 1e923fee-02d0-4682-9ffd-db824d02529f -->","subChapters":[]}]},{"id":"585f868d-097e-5bb1-acb7-5553c8aeef7d","slug":"diagnostic-referral-process","fullItemName":"Diagnostic and referral process","depth":3,"htmlHeader":"<!-- begin field 8c2bfd46-530c-41e0-b414-288936b06f31 --><h3>Diagnostic and referral process</h3><!-- end field 8c2bfd46-530c-41e0-b414-288936b06f31 -->","summary":null,"htmlStringContent":"<!-- begin item 2849f3ca-2c2a-4424-9fc3-609b35b9f2c2 --><!-- begin field a183bfdf-27e8-4f03-942b-6d0dda5375cb --><ul><li>Discussion with a specialist (for example, by telephone or email) should be considered if there is uncertainty about the interpretation of symptoms and signs, and whether a referral is needed. This may also enable the primary healthcare professional to communicate their concerns and a sense of urgency to secondary healthcare professionals when symptoms are not classical.</li><li>Put in place local arrangements to ensure that letters about non-urgent referrals are assessed by the specialist, so that the person can be seen more urgently if necessary.</li><li>Put in place local arrangements to ensure that there is a maximum waiting period for non-urgent referrals, in accordance with national targets and local arrangements.</li><li>Ensure local arrangements are in place to identify people who miss their appointments so that they can be followed up.</li><li>Include all appropriate information in referral correspondence, including whether the referral is urgent or non-urgent.</li><li>Use local referral proformas if these are in use.</li><li>Once the decision to refer has been made, make sure that the referral is made within 1 working day.</li><li>Take part in continuing education, peer review, and other activities to improve and maintain clinical consulting, reasoning, and diagnostic skills, in order to identify at an early stage people who may have cancer, and to communicate the possibility of cancer to the person.</li></ul><!-- end field a183bfdf-27e8-4f03-942b-6d0dda5375cb --><!-- end item 2849f3ca-2c2a-4424-9fc3-609b35b9f2c2 -->","subChapters":[{"id":"0d24b220-5d20-5d4b-9eb6-8c279ca9402e","slug":"basis-for-recommendation-87a","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field fa687cbe-aaae-4ba5-9572-cf1ce67c7b73 --><h4>Basis for recommendation</h4><!-- end field fa687cbe-aaae-4ba5-9572-cf1ce67c7b73 -->","summary":null,"htmlStringContent":"<!-- begin item 87a7bef5-3d72-4a0b-99eb-3a6e86210ad2 --><!-- begin field 12d445b9-ed87-41a0-96f3-3bbcbb10c00d --><p>This is a direct implementation of the National Institute for Health and Care Excellence guideline <em>Suspected cancer: recognition and r</em><em>eferral</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/gynaecological-cancers-recognition-referral/references/\">NICE, 2015</a>].</p><!-- end field 12d445b9-ed87-41a0-96f3-3bbcbb10c00d --><!-- end item 87a7bef5-3d72-4a0b-99eb-3a6e86210ad2 -->","subChapters":[]}]},{"id":"d5d0eca9-5516-5ddd-9944-d1f1fad301e0","slug":"patient-information-support","fullItemName":"Patient information and support","depth":3,"htmlHeader":"<!-- begin field b099550b-c866-4abe-ac8d-5ae3359c45c2 --><h3>What patient information and support should I offer?</h3><!-- end field b099550b-c866-4abe-ac8d-5ae3359c45c2 -->","summary":null,"htmlStringContent":"<!-- begin item 8c5df554-de2f-4c2e-b51c-cea5dea5e986 --><!-- begin field b56945a7-1e2c-4a8a-9a18-4c2ab638ad91 --><ul><li>Discuss with people with suspected cancer (and their carers as appropriate, taking account of the need for confidentiality) their preferences for being involved in decision-making about referral options and further investigations including their potential risks and benefits.</li><li>Explain to people who are being referred with suspected cancer that they are being referred to a cancer service. Reassure them, as appropriate, that most people referred will not have a diagnosis of cancer, and discuss alternative diagnoses with them.</li><li>Give the person information on the possible diagnosis (both benign and malignant) in accordance with their wishes for information.</li><li>The information given to people with suspected cancer and their families and/or carers should cover, among other issues:<ul><li>Where the person is being referred to.</li><li>How long they will have to wait for the appointment.</li><li>How to obtain further information about the type of cancer suspected or help before the specialist appointment.</li><li>What to expect from the service the person will be attending.</li><li>What type of tests may be carried out, and what will happen during diagnostic procedures.</li><li>How long it will take to get a diagnosis or test results.</li><li>Whether they can take someone with them to the appointment.</li><li>Who to contact if they do not receive confirmation of an appointment.</li><li>Other sources of support.</li></ul></li><li>Provide information that is appropriate for the person in terms of language, ability, and culture, recognizing the potential for different cultural meanings associated with the possibility of cancer.</li><li>Have information available in a variety of formats on both local and national sources of information and support for people who are being referred with suspected cancer.</li><li>When referring a person with suspected cancer to a specialist service, assess their need for continuing support while waiting for their referral appointment. This should include inviting the person to contact their healthcare professional again if they have more concerns or questions before they see a specialist.</li><li>If the person has additional support needs because of their personal circumstances, inform the specialist (with the person's agreement).</li><li>When cancer is suspected in a child, discuss the referral decision and information to be given to the child with the parents or carers (and the child if appropriate).</li></ul><!-- end field b56945a7-1e2c-4a8a-9a18-4c2ab638ad91 --><!-- end item 8c5df554-de2f-4c2e-b51c-cea5dea5e986 -->","subChapters":[{"id":"31b1a6ef-2701-54aa-9fb6-9d4b50ccaa27","slug":"basis-for-recommendation-f4b","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field 4d23f449-d10c-41f5-92b6-c62854d6bdde --><h4>Basis for recommendation</h4><!-- end field 4d23f449-d10c-41f5-92b6-c62854d6bdde -->","summary":null,"htmlStringContent":"<!-- begin item f4bd7418-88b5-4cd5-a2f0-2c1e600d4c91 --><!-- begin field fa517131-236e-4c90-a138-f772961e1458 --><p>This is a direct implementation of the National Institute for Health and Care Excellence guideline <em>Suspected cancer: recognition and r</em><em>eferral</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/gynaecological-cancers-recognition-referral/references/\">NICE, 2015</a>].</p><!-- end field fa517131-236e-4c90-a138-f772961e1458 --><!-- end item f4bd7418-88b5-4cd5-a2f0-2c1e600d4c91 -->","subChapters":[]}]},{"id":"b33eaeaf-744f-5b05-a560-073f18c6b2ae","slug":"safety-netting","fullItemName":"Safety netting","depth":3,"htmlHeader":"<!-- begin field 58aca1c1-583d-47ae-a1d0-ea89d6b62769 --><h3>Safety netting</h3><!-- end field 58aca1c1-583d-47ae-a1d0-ea89d6b62769 -->","summary":null,"htmlStringContent":"<!-- begin item 4210ac5a-6a4b-49ef-a90c-37e911345a45 --><!-- begin field 4ed0fd22-9be1-4071-b3d6-ae1907812af9 --><ul><li>Safety netting involves active monitoring of low risk people presenting with symptoms in primary care.</li><li>Explain to people who are being offered safety netting which symptoms to look out for and when they should return for re-evaluation. It may be appropriate to provide written information.</li><li>Reassure people in the safety netting group who are concerned that they may have cancer that with their current symptoms their risk of having cancer is low.</li><li>Ensure that the results of investigations are reviewed and acted upon appropriately, with the healthcare professional who ordered the investigation taking or explicitly passing on responsibility for this. Be aware of the possibility of false-negative results for chest X-rays and tests for occult blood in faeces.</li><li>Consider a review for people with any symptom that is associated with an increased risk of cancer, but who do not meet the criteria for referral or other investigative action. The review may be planned within a time frame agreed with the person or patient-initiated if new symptoms develop, the person continues to be concerned, or their symptoms recur, persist, or worsen.</li></ul><!-- end field 4ed0fd22-9be1-4071-b3d6-ae1907812af9 --><!-- end item 4210ac5a-6a4b-49ef-a90c-37e911345a45 -->","subChapters":[{"id":"b1ce7cd7-2f9e-58c2-ad25-a1d7562d37fb","slug":"basis-for-recommendation-3b1","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field dd318cc5-b692-48bc-8036-6d2fe527aa65 --><h4>Basis for recommendation</h4><!-- end field dd318cc5-b692-48bc-8036-6d2fe527aa65 -->","summary":null,"htmlStringContent":"<!-- begin item 3b1c0d35-6462-4797-9642-84a4b2a3b62d --><!-- begin field 521f2ab1-bd71-4b6b-99b5-4e35632ceebc --><p>This is a direct implementation of the National Institute for Health and Care Excellence guideline <em>Suspected cancer: recognition and r</em><em>eferral</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/gynaecological-cancers-recognition-referral/references/\">NICE, 2015</a>].</p><!-- end field 521f2ab1-bd71-4b6b-99b5-4e35632ceebc --><!-- end item 3b1c0d35-6462-4797-9642-84a4b2a3b62d -->","subChapters":[]}]}]}}},"staticQueryHashes":["3666801979"]}